SNOA vs STE · rev $19.5M vs P/E 25, rev $5.46B
Sonoma Pharmaceuticals Inc (SNOA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
SNOA currently screens at market cap $4.9M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the SNOA and STE stock pages for the full models.
Not investment advice.